Collegium Pharmaceutical, Inc.

NasdaqGS:COLL Stok Raporu

Piyasa değeri: US$967.5m

Collegium Pharmaceutical Yönetim

Yönetim kriter kontrolleri 2/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Vikram Karnani

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesin/a
CEO görev süresino data
CEO sahipliğin/a
Yönetim ortalama görev süresi4.3yrs
Yönetim Kurulu ortalama görev süresi10.3yrs

Son yönetim güncellemeleri

Recent updates

Shareholders Can Be Confident That Collegium Pharmaceutical's (NASDAQ:COLL) Earnings Are High Quality

Nov 14
Shareholders Can Be Confident That Collegium Pharmaceutical's (NASDAQ:COLL) Earnings Are High Quality

Is Collegium Pharmaceutical (NASDAQ:COLL) A Risky Investment?

Oct 28
Is Collegium Pharmaceutical (NASDAQ:COLL) A Risky Investment?

Collegium Pharmaceutical: Diversifying And Growing

Aug 09

Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) Price Is Right But Growth Is Lacking

Jul 24
Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) Price Is Right But Growth Is Lacking

Collegium Pharmaceutical (NASDAQ:COLL) Seems To Use Debt Quite Sensibly

Jun 05
Collegium Pharmaceutical (NASDAQ:COLL) Seems To Use Debt Quite Sensibly

Collegium Pharmaceutical: Some Positives From Its Quarterly 'Miss'

May 13

It Looks Like Shareholders Would Probably Approve Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) CEO Compensation Package

May 10
It Looks Like Shareholders Would Probably Approve Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) CEO Compensation Package

Collegium Pharmaceutical Q4: The Beat Goes On

Feb 26

These 4 Measures Indicate That Collegium Pharmaceutical (NASDAQ:COLL) Is Using Debt Reasonably Well

Feb 24
These 4 Measures Indicate That Collegium Pharmaceutical (NASDAQ:COLL) Is Using Debt Reasonably Well

There's No Escaping Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) Muted Revenues

Jan 05
There's No Escaping Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) Muted Revenues

Here's Why Collegium Pharmaceutical (NASDAQ:COLL) Can Manage Its Debt Responsibly

Nov 12
Here's Why Collegium Pharmaceutical (NASDAQ:COLL) Can Manage Its Debt Responsibly

Is Collegium Pharmaceutical (NASDAQ:COLL) Using Too Much Debt?

Aug 09
Is Collegium Pharmaceutical (NASDAQ:COLL) Using Too Much Debt?

Is Collegium Pharmaceutical (NASDAQ:COLL) A Risky Investment?

Mar 10
Is Collegium Pharmaceutical (NASDAQ:COLL) A Risky Investment?

Is Collegium Pharmaceutical (NASDAQ:COLL) Using Too Much Debt?

Oct 18
Is Collegium Pharmaceutical (NASDAQ:COLL) Using Too Much Debt?

Collegium Pharmaceutical (NASDAQ:COLL) Has A Somewhat Strained Balance Sheet

Jun 24
Collegium Pharmaceutical (NASDAQ:COLL) Has A Somewhat Strained Balance Sheet

Collegium Pharmaceutical: Oversold And Cheap

Jun 12

CEO

Vikram Karnani (49 yo)

no data

Görev süresi

Mr. Vikram Karnani is CEO, President & Director of Collegium Pharmaceutical, Inc. since November 12, 2024. Mr. Karnani was Executive Vice President and President, Global Commercial Operations and Medical A...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Michael Heffernan
Co-Founder & Chairman21.1yrsUS$330.61k0.087%
$ 840.7k
Colleen Tupper
Executive VP & CFO3.5yrsUS$2.73m0.061%
$ 591.3k
Shirley Kuhlmann
Executive VP6.7yrsUS$2.87m0%
$ 0
Scott Dreyer
Executive VP & Chief Commercial Officer6.3yrsUS$2.61m0%
$ 0
Thomas Smith
Executive VP & Chief Medical Officer2.7yrsUS$2.04m0%
$ 0
Vikram Karnani
CEO, President & Directorno dataVeri yokVeri yok
Christopher James
Vice President of Investor Relationsno dataVeri yokVeri yok
Bart Dunn
Executive Vice President of Strategy & Corporate Development5.2yrsVeri yokVeri yok
Scott Sudduth
Head of Technical Operations3.1yrsVeri yokVeri yok

4.3yrs

Ortalama Görev Süresi

50.5yo

Ortalama Yaş

Deneyimli Yönetim: COLL 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 4.3 yıldır).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Michael Heffernan
Co-Founder & Chairman21.1yrsUS$330.61k0.087%
$ 840.7k
Vikram Karnani
CEO, President & Directorno dataVeri yokVeri yok
John Freund
Independent Director10.8yrsUS$298.61k0.22%
$ 2.1m
Garen Bohlin
Independent Director9.8yrsUS$299.61k0.0073%
$ 70.6k
Gino Santini
Lead Independent Director12.3yrsUS$322.61k0.079%
$ 763.3k
Bill McCarberg
Scientific Advisorno dataVeri yokVeri yok
Robert Dworkin
Scientific Advisorno dataVeri yokVeri yok
Lynn Webster
Scientific Advisorno dataVeri yokVeri yok
John Fallon
Independent Director8.4yrsUS$289.61k0.12%
$ 1.1m
Cynthia McCormick
Scientific Advisorno dataVeri yokVeri yok
Richard Rauck
Scientific Advisorno dataVeri yokVeri yok
Charles Argoff
Scientific Advisorno dataVeri yokVeri yok

10.3yrs

Ortalama Görev Süresi

68.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: COLL 'in yönetim kurulu deneyimli ve tecrübelidir (ortalama görev süresi 10.3 yıldır).